Bionano Genomics, Inc. (BNGO) Dividend History

Company News

• Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

  Bionano Genomics announced a $10 million registered direct offering, with the proceeds to be used for general corporate purposes. The offering includes the sale of common stock and warrants to institutional investors.

  GlobeNewswire Inc.
• Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

  Bionano Genomics announced an amendment to its senior secured convertible debentures, which defers near-term debt payments and reduces cash needs, strengthening the company's capital structure and improving its near-term liquidity position.

  GlobeNewswire Inc.
• Bionano Announces Preliminary 3Q 2024 Revenues and Cash

  Bionano Genomics expects lower-than-expected revenue for Q3 2024, citing a strategic shift in the business and continued headwinds in the tools and diagnostics sector. The company remains focused on driving utilization and adoption of its optical genome mapping (OGM) technology from its existing installed base.

  GlobeNewswire Inc.
• 10 Consumer Discretionary Stocks With Whale Alerts In Today's Session - Benzinga

  The article discusses options activity in 10 consumer discretionary stocks, including Tesla, Jumia, Caesars Entertainment, eBay, Brunswick, Wayfair, Amazon, Lululemon, Bionano Genomics, and Lowe's. It provides details on the options trades, including the expiration date, strike price, sentiment, and reasoning for the sentiment.

  Benzinga

  Featured Companies: AMZN BC CZR EBAY LOW LULU TSLA W
• Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript

  BNGO earnings call for the period ending March 31, 2024.

  The Motley Fool